According to a new report from Intel Market Research, the global Amide HPLC Column market was valued at USD 151 million in 2025 and is projected to reach USD 203 million by 2034, growing at a CAGR of 4.4% during the forecast period (2026–2034). This growth is propelled by rising demand in pharmaceutical quality control, biotechnology research, food safety testing, environmental monitoring, and advancements in hydrophilic interaction liquid chromatography (HILIC) for polar analytes.
What is Amide HPLC Column?
Amide HPLC Column is a specialized type of High-Performance Liquid Chromatography (HPLC) column that uses amide-functionalized stationary phases. This design makes it particularly suitable for analyzing polar compounds, such as carbohydrates, peptides, and other hydrophilic molecules, which can be challenging to separate with conventional reversed-phase columns.
This report provides a deep insight into the global Amide HPLC Column market covering all its essential aspects-from a macro overview of the market to micro details such as market size, competitive landscape, development trends, niche markets, key drivers and challenges, SWOT analysis, and value chain analysis.
The analysis helps the reader understand competition within the industry and strategies for enhancing profitability. Furthermore, it provides a framework for evaluating and accessing the position of a business organization. The report also focuses on the competitive landscape of the Global Amide HPLC Column Market, introducing market share, performance, product positioning, and operational insights of major players. This helps industry professionals identify key competitors and understand the competition pattern.
In short, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those planning to foray into the Amide HPLC Column market.
? Download Sample Report: https://www.intelmarketresearch.com/download-free-sample/41940/amide-hplc-column-market
Key Market Drivers
1. Advancements in Pharmaceutical Analytics
The Amide HPLC Column Market is propelled by increasing investments in pharmaceutical R&D, where these columns excel in separating polar compounds under HILIC conditions. With global biopharmaceutical production projected to reach $500 billion by 2025, demand for high-resolution amide-based stationary phases has surged, enabling precise analysis of peptides and glycans.
2. Expansion in Biotechnology Sectors
Biotech firms are adopting amide HPLC columns for proteomics workflows, as they offer superior retention for hydrophilic analytes compared to traditional C18 phases. This shift supports the growing need for quality control in monoclonal antibody development, with the segment contributing over 35% to market growth annually. Additionally, regulatory pressures for faster method development in drug impurity profiling further boost adoption.
? Proteomics applications alone drive 25% YoY increase in amide column shipments worldwide.
Market Challenges
Technical Compatibility Issues – Limited compatibility with standard reverse-phase systems, requiring specialized mobile phases like high acetonitrile concentrations. This can lead to inconsistent peak shapes for certain metabolites, complicating method transfers across labs and increasing validation time by up to 20%.
High Maintenance Demands – Amide columns suffer from faster degradation under extreme pH conditions, necessitating frequent replacements and driving operational costs 15-20% higher than silica-based alternatives, particularly in high-throughput environments.
Supply Chain Disruptions – Disruptions for raw amide-functionalized silica materials exacerbate availability issues, with lead times extending beyond 8 weeks in peak demand periods, hindering scalability for contract research organizations.
Emerging Opportunities
The global analytical landscape is becoming increasingly favorable for advanced chromatography solutions. Growing regulatory scrutiny in food safety and environmental sectors, along with investments in UHPLC technologies, are accelerating market expansion, especially in Asia-Pacific, Latin America, and the Middle East & Africa. Key growth enablers include:
Growing food and beverage testing for polar contaminants like pesticides, expected to drive a 12% CAGR in this vertical through 2030.
Integration with UHPLC systems for enhanced resolution in complex samples, particularly in water quality analysis.
Localized manufacturing in Asia-Pacific, potentially capturing 20% additional share as local pharma hubs invest in advanced tools for export compliance.
Collectively, these factors are expected to enhance accessibility, stimulate innovation, and drive Amide HPLC Column penetration across new applications and geographies.
? Download Sample PDF: https://www.intelmarketresearch.com/download-free-sample/41940/amide-hplc-column-market
Regional Market Insights
North America: North America maintains the largest share of the global Amide HPLC Column market, driven by its pharmaceutical and biopharmaceutical research ecosystem, robust FDA/EPA regulations, and early adoption of UHPLC technologies.
Europe: Europe is a key market supported by mature pharma manufacturing in Germany, Switzerland, UK, and France, with EMA validation requirements boosting demand for amide columns.
Asia-Pacific and Latin America: These regions represent high-potential growth frontiers, with rapid pharma expansion in China, India, Brazil, and improving lab infrastructure.
Middle East and Africa: Emerging growth due to investments in pharma manufacturing and food safety in GCC countries and South Africa.
Market Segmentation
By Type
Conventional Reverse Phase Amide Chromatography Columns
Hydrophilic Interaction Chromatography (HILIC) Amide Columns
By Application
Pharmaceutical
Biotechnology
Food Safety
Environmental Monitoring
Others
By End User
Pharmaceutical & Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
Food & Beverage Testing Laboratories
Environmental Testing Laboratories
By Column Dimension
Analytical Columns
Semi-Preparative Columns
Preparative Columns
By Particle Size
Sub-2 µm Particles (UHPLC-compatible)
2–3.5 µm Particles
Above 3.5 µm Particles
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
? Get Full Report: https://www.intelmarketresearch.com/amide-hplc-column-market-41940
Competitive Landscape
While Waters Corporation and Agilent Technologies dominate the current market, several specialized manufacturers are strengthening their positions in HILIC and polar separations.
The report provides in-depth competitive profiling of key players, including:
Waters Corporation
Agilent Technologies
Thermo Fisher Scientific
Sigma-Aldrich (MilliporeSigma)
Shimadzu Corporation
Tosoh Corporation
Dikma Technologies
Hawach Scientific
Orochem Technologies
Troody
Saintins
Report Deliverables
Global and regional market forecasts from 2026 to 2034
Strategic insights into technology trends, R&D innovations, and regulatory approvals
Market share analysis and SWOT assessments
Pricing trends and supply chain dynamics
Comprehensive segmentation by type, application, end user, and geography
? Get Full Report: https://www.intelmarketresearch.com/amide-hplc-column-market-41940
? Download Sample Report: https://www.intelmarketresearch.com/download-free-sample/41940/amide-hplc-column-market
About Intel Market Research
Intel Market Research is a leading provider of strategic intelligence, offering actionable insights in biotechnology, pharmaceuticals, and healthcare infrastructure. Our research capabilities include:
Real-time competitive benchmarking
Global clinical trial pipeline monitoring
Country-specific regulatory and pricing analysis
Over 500+ healthcare reports annually
Trusted by Fortune 500 companies, our insights empower decision-makers to drive innovation with confidence.
? Website: https://www.intelmarketresearch.com
? Asia-Pacific: +91 9169164321
? LinkedIn: Follow Us
Comments